Nurr1 regulates Top IIβ and functions in axon genesis of mesencephalic dopaminergic neurons

Molecular Neurodegeneration

Volumn 7, Issue 1, 2012, Pages

  Heng, Xin ^a,b   Jin, Gang ^b   Zhang, Xin ^a   Yang, Dehuang ^b   Zhu, Mingzhe ^b   Fu, Shijun ^b   Li, Xuping ^c   Le, Weidong ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE; GENE FUNCTION; GENE INACTIVATION; MEDIAL FOREBRAIN BUNDLE; MESENCEPHALON; MOUSE; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NURR1 GENE; TOP IIBETA GENE; ANIMAL; CELL SHAPE; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; NEWBORN;

MUS;

4,4' (1,2 DIMETHYL 1,2 ETHANEDIYL)BIS 2,6 PIPERAZINEDIONE; 4,4'-(1,2-DIMETHYL-1,2-ETHANEDIYL)BIS-2,6-PIPERAZINEDIONE; DNA BINDING PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE II BETA; GYRASE INHIBITOR; NUCLEAR RECEPTOR RELATED FACTOR 1; PIPERAZINE DERIVATIVE;

ANIMALS; ANIMALS, NEWBORN; AXONS; CELL SHAPE; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; DOPAMINERGIC NEURONS; DOWN-REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MESENCEPHALON; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PIPERAZINES; TOPOISOMERASE II INHIBITORS;

EID: 84862817207     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-7-4     Document Type: Article

References (49)

1. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach JP, Conneely OM, Proc Natl Acad Sci USA 1998 95 7 4013 4018 10.1073/pnas.95.7.4013 9520484 (Pubitemid 28173245)
2. Progress in the clinical and molecular genetics of familial parkinsonism. Kitada T, Asakawa S, Matsumine H, Hattori N, Shimura H, Minoshima S, Shimizu N, Mizuno Y, Neurogenetics 2000 2 4 207 218 10.1007/s100489900083 10983716 (Pubitemid 30195999)
3. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells. Taylor H, Minger SL, Curr Opin Biotechnol 2005 16 5 487 492 10.1016/j.copbio.2005.08.005 16143504 (Pubitemid 41393826)
4. Stem cell treatment for Parkinson's disease: an update for 2005. Snyder BJ, Olanow CW, Curr Opin Neurol 2005 18 4 376 385 10.1097/01.wco.0000174298. 27765.91 16003112 (Pubitemid 41104799)
5. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Forman BM, Umesono K, Chen J, Evans RM, Cell 1995 81 4 541 550 10.1016/0092-8674(95)90075-6 7758108
6. Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Bannon MJ, Pruetz B, Manning-Bog AB, Whitty CJ, Michelhaugh SK, Sacchetti P, Granneman JG, Mash DC, Schmidt CJ, Proc Natl Acad Sci USA 2002 99 9 6382 6385 10.1073/pnas.092654299 11959923 (Pubitemid 34493320)
7. Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells. Hermanson E, Joseph B, Castro D, Lindqvist E, Aarnisalo P, Wallen A, Benoit G, Hengerer B, Olson L, Perlmann T, Exp Cell Res 2003 288 2 324 334 10.1016/S0014-4827(03)00216-7 12915123 (Pubitemid 36959948)
8. Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. Kim KS, Kim CH, Hwang DY, Seo H, Chung S, Hong SJ, Lim JK, Anderson T, Isacson O, J Neurochem 2003 85 3 622 634 10.1046/j.1471-4159.2003.01671.x 12694388 (Pubitemid 36531925)
9. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Jankovic J, Chen S, Le WD, Prog Neurobiol 2005 77 1-2 128 138 10.1016/j.pneurobio.2005.09.001 16243425 (Pubitemid 41654775)
10. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. Le W, Conneely OM, He Y, Jankovic J, Appel SH, J Neurochem 1999 73 5 2218 2221 10537083 (Pubitemid 29491838)
11. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Jiang C, Wan X, He Y, Pan T, Jankovic J, Le W, Exp Neurol 2005 191 1 154 162 10.1016/j.expneurol.2004.08.035 15589522 (Pubitemid 39612401)
12. Decreased NURR1 gene expression in patients with Parkinson's disease. Le W, Pan T, Huang M, Xu P, Xie W, Zhu W, Zhang X, Deng H, Jankovic J, J Neurol Sci 2008 273 1-2 29 33 10.1016/j.jns.2008.06.007 18684475
13. Mutations in NR4A2 associated with familial Parkinson disease. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK, Nat Genet 2003 33 1 85 89 10.1038/ng1066 12496759 (Pubitemid 36068688)
14. Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity. Eells JB, Lipska BK, Yeung SK, Misler JA, Nikodem VM, Behav Brain Res 2002 136 1 267 275 10.1016/S0166-4328(02)00185-7 12385813 (Pubitemid 35246412)
15. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Wallen A, Zetterstrom RH, Solomin L, Arvidsson M, Olson L, Perlmann T, Exp Cell Res 1999 253 2 737 746 10.1006/excr.1999.4691 10585298 (Pubitemid 30003136)
16. Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem. Wallen AA, Castro DS, Zetterstrom RH, Karlen M, Olson L, Ericson J, Perlmann T, Mol Cell Neurosci 2001 18 6 649 663 10.1006/mcne.2001.1057 11749040 (Pubitemid 34060146)
17. Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. Castro DS, Hermanson E, Joseph B, Wallen A, Aarnisalo P, Heller A, Perlmann T, J Biol Chem 2001 276 46 43277 43284 10.1074/jbc.M107013200 11553630
18. Neuropilin1 is a direct downstream target of Nurr1 in the developing brain stem. Hermanson E, Borgius L, Bergsland M, Joodmardi E, Perlmann T, J Neurochem 2006 97 5 1403 1411 10.1111/j.1471-4159.2006.03829.x 16638018 (Pubitemid 43725579)
19. Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons. Jacobs FM, van der Linden AJ, Wang Y, von Oerthel L, Sul HS, Burbach JP, Smidt MP, Development 2009 136 14 2363 2373 10.1242/dev.037556 19515692
20. The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1). Nemes JP, Benzow KA, Moseley ML, Ranum LP, Koob MD, Hum Mol Genet 2000 9 10 1543 1551 10.1093/hmg/9.10.1543 10888605 (Pubitemid 30386709)
21. KLHL1/MRP2 mediates neurite outgrowth in a glycogen synthase kinase 3beta-dependent manner. Seng S, Avraham HK, Jiang S, Venkatesh S, Avraham S, Mol Cell Biol 2006 26 22 8371 8384 10.1128/MCB.02167-05 16982692 (Pubitemid 44748571)
22. Receptor tyrosine phosphatases guide vertebrate motor axons during development. Stepanek L, Stoker AW, Stoeckli E, Bixby JL, J Neurosci 2005 25 15 3813 3823 10.1523/JNEUROSCI.4531-04.2005 15829633 (Pubitemid 40570414)
23. Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively. Tan KB, Dorman TE, Falls KM, Chung TD, Mirabelli CK, Crooke ST, Mao J, Cancer Res 1992 52 1 231 234 1309226
24. DNA topoisomerase IIbeta and neural development. Yang X, Li W, Prescott ED, Burden SJ, Wang JC, Science 2000 287 5450 131 134 10.1126/science.287.5450. 131 10615047 (Pubitemid 30033236)
25. Role of topoisomerase IIbeta in the expression of developmentally regulated genes. Lyu YL, Lin CP, Azarova AM, Cai L, Wang JC, Liu LF, Mol Cell Biol 2006 26 21 7929 7941 10.1128/MCB.00617-06 16923961 (Pubitemid 44630993)
26. Role of DNA topoisomerase IIbeta in neurite outgrowth. Nur EKA, Meiners S, Ahmed I, Azarova A, Lin CP, Lyu YL, Liu LF, Brain Res 2007 1154 50 60 17493591 (Pubitemid 46856345)
27. Congenital hypoventilation and impaired hypoxic response in Nurr1 mutant mice. Nsegbe E, Wallen-Mackenzie A, Dauger S, Roux JC, Shvarev Y, Lagercrantz H, Perlmann T, Herlenius E, J Physiol 2004 556 Pt 1 43 59 14742729 (Pubitemid 38515168)
28. Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta. Lyu YL, Wang JC, Proc Natl Acad Sci USA 2003 100 12 7123 7128 10.1073/pnas.1232376100 12773624 (Pubitemid 36706403)
29. Nr4a2 is essential for the differentiation of dopaminergic neurons during zebrafish embryogenesis. Luo GR, Chen Y, Li XP, Liu TX, Le WD, Mol Cell Neurosci 2008 39 2 202 210 10.1016/j.mcn.2008.06.010 18638558
30. Chloride channels activated by hypotonicity in N2A neuroblastoma cell line. Carpaneto A, Accardi A, Pisciotta M, Gambale F, Exp Brain Res 1999 124 2 193 199 10.1007/s002210050614 9928842 (Pubitemid 29134419)
31. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Wilson TE, Fahrner TJ, Johnston M, Milbrandt J, Science 1991 252 5010 1296 1300 10.1126/science.1925541 1925541 (Pubitemid 21917041)
32. Differential regulation of transcription by the NURR1/NUR77 subfamily of nuclear transcription factors. Murphy EP, Dobson AD, Keller C, Conneely OM, Gene Expr 1996 5 3 169 179 8882640 (Pubitemid 3037526)
33. 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. Mao Y, Desai SD, Ting CY, Hwang J, Liu LF, J Biol Chem 2001 276 44 40652 40658 10.1074/jbc.M104009200 11546768
34. Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. Osheroff N, Biochemistry 1989 28 15 6157 6160 10.1021/bi00441a005 2551366 (Pubitemid 19202003)
35. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. Cheng LE, Chan FK, Cado D, Winoto A, EMBO J 1997 16 8 1865 1875 10.1093/emboj/16.8.1865 9155013 (Pubitemid 27170948)
36. Three related brain nuclear receptors, NGFI-B, Nurr1, and NOR-1, as transcriptional activators. Paulsen RF, Granas K, Johnsen H, Rolseth V, Sterri S, J Mol Neurosci 1995 6 4 249 255 10.1007/BF02736784 8860236
37. Ascending projections of presumed dopamine-containing neurons in the ventral tegmentum of the rat as demonstrated by horseradish peroxidase. Carter DA, Fibiger HC, Neuroscience 1977 2 4 569 576 10.1016/0306-4522(77)90052-5 917282 (Pubitemid 8179763)
38. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG, Science 2006 312 5781 1798 1802 10.1126/science.1127196 16794079 (Pubitemid 43962898)
39. Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment. Sano K, Miyaji-Yamaguchi M, Tsutsui KM, Tsutsui K, PLoS One 2008 3 12 4103 10.1371/journal.pone.0004103 19116664
40. Analysis of age dependent changes of Topoisomerase II alpha and beta in rat brain. Kondapi AK, Mulpuri N, Mandraju RK, Sasikaran B, Subba Rao K, Int J Dev Neurosci 2004 22 1 19 30 10.1016/j.ijdevneu.2003.10.006 15013075 (Pubitemid 38169494)
41. Cultured cerebellar granule neurons as an in vitro aging model: topoisomerase IIbeta as an additional biomarker in DNA repair and aging. Bhanu MU, Mandraju RK, Bhaskar C, Kondapi AK, Toxicol In Vitro 24 7 1935 1945
42. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Barnes DE, Stamp G, Rosewell I, Denzel A, Lindahl T, Curr Biol 1998 8 25 1395 1398 10.1016/S0960-9822(98)00021-9 9889105 (Pubitemid 29020149)
43. Involvement of DNA topoisomerase IIbeta in neuronal differentiation. Tsutsui K, Sano K, Kikuchi A, Tokunaga A, J Biol Chem 2001 276 8 5769 5778 10.1074/jbc.M008517200 11106659
44. Topoisomerase II poisoning by ICRF-193. Huang KC, Gao H, Yamasaki EF, Grabowski DR, Liu S, Shen LL, Chan KK, Ganapathi R, Snapka RM, J Biol Chem 2001 276 48 44488 44494 10.1074/jbc.M104383200 11577077
45. The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway. Xiao H, Mao Y, Desai SD, Zhou N, Ting CY, Hwang J, Liu LF, Proc Natl Acad Sci USA 2003 100 6 3239 3244 10.1073/pnas.0736401100 12629207 (Pubitemid 36356567)
46. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, Henley JR, Rocca WA, Ahlskog JE, Maraganore DM, PLoS Genet 2007 3 6 98 10.1371/journal.pgen.0030098 17571925 (Pubitemid 47015858)
47. Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Lin L, Lesnick TG, Maraganore DM, Isacson O, Trends Neurosci 2009 32 3 142 149 10.1016/j.tins.2008.11.006 19162339
48. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Le W, Conneely OM, Zou L, He Y, Saucedo-Cardenas O, Jankovic J, Mosier DR, Appel SH, Exp Neurol 1999 159 2 451 458 10.1006/exnr.1999.7191 10506516 (Pubitemid 29485231)
49. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo. Du Y, Li X, Yang D, Zhang X, Chen S, Huang K, Le W, Exp Biol Med (Maywood) 2008 233 7 881 890 10.3181/0712-RM-329